STIP1 and ovarian carcinoma: In ovarian cancer cells treated with rhSTIP1, siRNA knockdown of STIP1, or anti-STIP1 antibodies, we also used MTT assays to evaluate cell viability as a proxy for the cell number, with the understanding that cell number is shaped by the forces of both cell proliferation and apoptosis.